Phase II study of obatoclax mesylate (GX15-070), a small-molecule BCL-2 family antagonist, for patients with myelofibrosis (Q33391404)
scientific article
Language:
Current Data About Phase II study of obatoclax mesylate (GX15-070), a small-molecule BCL-2 family antagonist, for patients with myelofibrosis
(P31) (Q13442814)
(P248)
(P698) 20709666
(P813) Wednesday, July 26, 2017

(P50) (Q56378117)
(P1932) Aaron Schimmer
(P1545) 3

(Q60394812)
(P1545) 2
(P1932) Hagop Kantarjian
(P248)
(P698) 20709666
(P813) Wednesday, July 26, 2017

(Q64026418)
(P1545) 8
(P1932) Srdan Verstovsek
(P248)
(P698) 20709666
(P813) Wednesday, July 26, 2017

(Q89056162)
(P1545) 1
(P1932) Sameer A Parikh
(P248)
(P698) 20709666
(P813) Wednesday, July 26, 2017

(Q117195033)
(P1545) 7
(P1932) Elliott Winton
(P248)
(P698) 20709666
(P813) Wednesday, July 26, 2017

(P304) 285-289
(P248)
(P698) 20709666
(P813) Wednesday, July 26, 2017

(P407) (Q1860)

(P433) 4
(P248)
(P698) 20709666
(P813) Wednesday, July 26, 2017

(P478) 10
(P248)
(P698) 20709666
(P813) Wednesday, July 26, 2017

(P577) Sunday, August 1, 2010
(P248)
(P698) 20709666
(P813) Wednesday, July 26, 2017

(P921) (Q1752571)
(P887)

(P1433) (Q5133774)
(P248)
(P698) 20709666
(P813) Wednesday, July 26, 2017

(P1476) "Phase II study of obatoclax mesylate (GX15-070), a small-molecule BCL-2 family antagonist, for patients with myelofibrosis" (language: en)
(P248)
(P698) 20709666
(P813) Wednesday, July 26, 2017

(P2093) William Walsh
(P1545) 4
(P248)
(P698) 20709666
(P813) Wednesday, July 26, 2017

Ekatherine Asatiani
(P1545) 5
(P248)
(P698) 20709666
(P813) Wednesday, July 26, 2017

Khaled El-Shami
(P1545) 6
(P248)
(P698) 20709666
(P813) Wednesday, July 26, 2017

other details
description scientific article

External Links
(P356) 10.3816/CLML.2010.N.059
(P698) 20709666